Grants Search Results

This grant supports the research team developing the Hematologic Malignancies Program at Connecticut Children's Medical Center. The program will provide clinical care for hematologic malignancy patients and enroll them on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Nurse who will also act as the Adolescent and Young Adult (AYA) Liaison to ensure that more kids, adolescents, and young adults can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Assistant to ensure that more kids can be treated on early-phase clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports clinical research personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds the Nurse Researchers in the UIC/Rush/Stroger COG Program to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports construction of a REDCap database that will capture valuable clinical information on demographics, diagnosis, and treatment information for adolescent and young adult (AYA) cancer patients. The grant also supports a Patient Care Navigator who maintains the REDcap database and works to coordinate resources with other departments. This database helps track patients over time, giving more information to researchers and providing better long-term care for childhood cancer survivors.

This grant supports the Defeat Pediatric Brain Tumors Research Collaborative, focused on helping kids with high-grade gliomas. The Collaborative is made up of four teams that study new targets for medicines, search brain cancer biomarkers, and conduct clinical trials, all to accelerate scientific discovery in pediatric brain tumors.

This consortium is conducting the first multi-institutional, genomics-based precision medicine trial for children with relapsed, refractory, and very high-risk leukemias. They are deploying new technologies to sequence all currently known cancer-promoting genes in an individual child's leukemia. Next, guided by a multi-disciplinary group of leukemia experts, they will make treatment recommendations based upon the genomic findings in the child's leukemia and the availability of a relevant targeted drugs for children. Results from this project will define the types and frequency of specific mutations in children with relapsed/refractory leukemia, and assess the impact of the treatment recommendations on their clinical care. The consortium will also perform laboratory-based studies to determine the response to therapy in lab models derived from the patient's leukemia cells, to identify new drug targets for these children. Data generated in this proposal will inform future genomically-based targeted therapy trials for children with leukemia with the long-term goal of precise, safe, and more efficacious therapies for children with these diseases. Funds administered by Dana-Farber Cancer Institute.

This grant is named for Hannah’s Heroes, a Hero Fund established to honor Hannah Meeson. At age 6 she was diagnosed with anaplastic medulloblastoma. After a relapse and additional treatment, Hannah currently shows no evidence of disease. Throughout her treatments, Hannah never complained and remained positive and happy. This fund pays tribute to her fight by raising awareness and funding for all childhood cancers because kids like Hannah “are worth fighting for.”

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.